Background: Cutaneous leishmaniasis is an important skin parasitic disease. Ideal treatment is not found yet and seeking for proper drugs continues. Objective: Comparison of the efficacy of fluconazole with systemic glucantime in patients with acute cutaneous leishmaniasis in Ghaem hospital in Mashhad in 2002. Patients and Methods: During one year of study, all patients with cutaneous leishmani...

Background: One approach for prevention of cutaneous leishmaniasis is creation of a barrier between the insect vector (phlebotomus) and the host.  Many, but not all, researchers claim that permethrin-impregnated uniforms are effective for prevention of cutaneous leishmaniasis.  We determined the efficacy of permethrin-impregnated uniforms for prevention of cutaneous leishmaniasis among Iranian ...

Background and objectives: Cutaneous leishmaniasis is endemic in most areas of Iran, and the diagnosis of its species is essential for controlling the disease. Leishmania major is the causative agent for cutaneous leishmaniasis in humans. Molecular methods are generally more sensitive than microscopic methods. The present study aimed to use a polymerase chain reaction-enzyme linked immunosorben...

Lymphoproliferative infiltrates could be seen in several skin diseases but they are very characteristic of cutaneous pseudolymphoma, which can mimic both clinically and histopathologically cutaneous malignant pseudolymphoma. A big problem for the clinicians is the differential diagnosis between cutaneous pseudolymphoma and malignant cutaneous lymphomas, as well as possibility for transformation...

Primary cutaneous lymphomas have a distinct clinical behavior and prognosis, and therefore require a different therapeutic approach, as compared with their primary nodal equivalents. The European Organization for Research and Treatment of Cancer (EORTC) classification for primary cutaneous lymphomas recognizes a limited number of cutaneous T-cell lymphomas and cutaneous B-cell lymphomas and is ...

AHNMD: associated clonal hematologic none mast cell lineage disease CM: cutaneous mastocytosis CMML: chronic myelomonocytic leukemia MPCM: maculopapular cutaneous mastocytosis SM: systemic mastocytosis INTRODUCTION Maculopapular cutaneous mastocytosis (MPCM) is the clinical variant of cutaneous mastocytosis (CM) most frequently observed in adults, usually within the context of an indolent syste...

Primary cutaneous plasmacytosis is an uncommon cutaneous disorder with multiple cutaneous nodules and plaques mainly on face and trunk. This entity is thought to be a reactive process with unknown etiology. Pulmonary involvement could be found as a part of systemic plasmacytosis whereas cutaneous plasmacytosis was also reported with other pulmonary disorders. This report presents the case of cu...

Background: Few reports represent palmar cutaneous nerve neuropathy in the wrist due to a ganglion cyst. Case Presentation: A 25-year-old female was presented with a mass at volar side of the wrist and hypoesthesia at the base of thenar eminence. At ulrasonographic examination, a simple cyst was detected. Sensory response of palmar cutaneous branch of median nerve was absent at the affec...

The clinical spectrum of cutaneous adverse drug reactions range from benign, self-limiting reactions to life-threatening conditions. Patients with severe cutaneous adverse drug reactions require longer hospitalisation that cost both the hospital and health care system. Cutaneous adverse drug reactions are common complications of medical therapy. While most are benign and self-limiting after wit...